Several compounds have demonstrated life-extending effects in animal models, some of which are currently being tested for their ability to exert anti-aging effects in...
Alkahest announced today that they have initiated a phase 2 clinical trial with funding from the Michael J. Fox Foundation (MJFF).
Today's press release reveals...
Start-up targets cell senescence therapies and near-term opportunities in advanced cosmetics market.
The market for the development of anti-senescence therapeutics is on fire and we’ve...
Stealthy anti-aging start-up kicks-off £2.6m fundraise to target both Alzheimer's and advanced cosmetics.
Many of the companies working in the Longevity sector are playing their...
AgeX Therapeutics has announced a research collaboration with an as-yet-undisclosed Japanese biopharm company to further the development of its immunotolerance technology platform.
AgeX is focused...
Top Yale lab spawns new company focused on development of glucosepane-cleaving drugs.
San Francisco based biotech start-up Revel Pharmaceuticals has announced itself to the...
“We're not trying to make billionaires live longer, we're trying to make everybody live longer.”
When it comes to thought leaders in the Longevity sector,...
While Phase 3 trial of RTB101 for respiratory illness did not meet primary endpoint, company presses-on with Parkinson’s trial for TORC1 inhibitor: Results expected...
AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity.
“I won’t tell you...
New proteomic discoveries reveal a link between levels of certain proteins in human plasma and aging.
The field of aging-targeting therapeutics is rapidly evolving. The...
Partnership sees AI platform expanded into drug repurposing and discovery.
Canadian AI technology firm NetraMark yesterday announced the extension of its NetraPharma collaboration agreement with...
Deep aging clocks – the emergence of Al-based biomarkers of aging and Longevity and their implications in the development of therapeutic restorative interventions that...
Bioquark looks to nature for the answers to regeneration and rejuvenation.
Last week, the BBC reported on the plight of axolotls in Mexico City, which...
Aging Analytics Agency profiles more than 50 biomarkers related to age-related diseases and syndromes.
Earlier this week, attendees at the AI for Longevity Summit at...
SENS Research Foundation launches Underdog - a new therapeutic approach to cardiovascular disease (CVD).
According to the World Health Organisation (WHO), cardiovascular diseases is the...
Telomerase therapy ready for human Alzheimer’s trials.
“There have been more than 400 registered trials for Alzheimer's and, by global consensus, every single one has...
Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres.
Inflammation is a double-edged sword; while it is necessary...
We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years.
One of the speakers at this month’s...
